Financial Services -
Insurance - Life - NASDAQ - US
$ 5.39
1.13 %
$ 515 M
Market Cap
-19.96
P/E
1. INTRINSIC VALUE
Balance Sheet
Abacus Life, Inc.
| Current Assets | 160 M |
| Cash & Short-Term Investments | 132 M |
| Receivables | 39.9 M |
| Other Current Assets | -12.3 M |
| Non-Current Assets | 715 M |
| Long-Term Investments | 376 M |
| PP&E | 5.75 M |
| Other Non-Current Assets | 333 M |
| Current Liabilities | 62.5 M |
| Accounts Payable | 0 |
| Short-Term Debt | 38.9 M |
| Other Current Liabilities | 23.5 M |
| Non-Current Liabilities | 388 M |
| Long-Term Debt | 347 M |
| Other Non-Current Liabilities | 41.4 M |
EFFICIENCY
Earnings Waterfall
Abacus Life, Inc.
| Revenue | 112 M |
| Cost Of Revenue | 11.4 M |
| Gross Profit | 101 M |
| Operating Expenses | 101 M |
| Operating Income | -888 K |
| Other Expenses | 24 M |
| Net Income | -24.9 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Abacus Life, Inc.
| Net Income | -24.9 M |
| Depreciation & Amortization | 7.91 M |
| Capital Expenditures | -805 K |
| Stock-Based Compensation | 43.4 M |
| Change in Working Capital | -196 M |
| Others | 13.2 |
| Free Cash Flow | -210 M |
Wall Street Analysts Price Targets
Abacus Life, Inc.
Wall Street analysts predict an average 1-year price target for ABL of $13.5 , with forecasts ranging from
a
low of
$12 to a high of $15 .
ABL Lowest Price Target
Wall Street Target
12 USD
122.63%
ABL Average Price Target
Wall Street Target
13.5 USD
150.46%
ABL Highest Price Target
Wall Street Target
15 USD
178.29%
4. DIVIDEND
ANALYSIS
ABL does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Abacus Life, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
22.4 M USD 4
9-12 MONTHS
0 USD 0
Bought
1.19 M USD 3
0-3 MONTHS
0 USD 0
3-6 MONTHS
280 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman
SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
globenewswire.com
- 4 days ago
Coventry Responds to Baseless Lawsuit by Abacus Global Management, Inc.
FORT WASHINGTON, Pa. , July 2, 2025 /PRNewswire/ -- Coventry, the leader and creator of the secondary market for life insurance, today released the following statement: "Abacus's (NASDAQ: ABL) lawsuit is its latest misdirection and a transparent ploy designed to delay accountability and deflect attention from serious problems of Abacus's own making," said Alan Buerger, Coventry's Chairman.
prnewswire.com
- 4 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
prnewswire.com
- 5 days ago
Abacus Global Management sues Coventry alleging defamation and anticompetitive conduct
Abacus Global Management (NASDAQ:ABL) announced that it has filed a lawsuit against Coventry First LLC and its chairman, Alan Buerger, alleging a coordinated campaign to defame the company and damage its business through anticompetitive practices. The complaint was filed in Florida's Ninth Circuit Court.
proactiveinvestors.com
- 5 days ago
Abacus Global Management Sues Coventry and its Chairman Alan Buerger for Defamation and Anticompetitive Conduct
Coventry and Chairman Alan Buerger Engaged in Years-Long Campaign to Systematically Disseminate False and Misleading Information About the Publicly-Traded Company
globenewswire.com
- 5 days ago
Wolf Popper LLP Announces Investigation on Behalf of Abacus Global Management, Inc. Investors
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. (“Abacus”) common stock (NASDAQ: ABL).
globenewswire.com
- 5 days ago
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman
SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
globenewswire.com
- 6 days ago
Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
ORLANDO, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its (i) outstanding public warrants (the “public warrants”) and (ii) outstanding private placement warrants (the “private placement warrants” and, together with the public warrants, the “warrants”) to purchase shares of common stock, par value $0.0001 per share, of the Company (“common stock”). The Company's common stock and public warrants are listed on the Nasdaq Capital Market under the symbols “ABL” and “ABLLW,” respectively. The purpose of the Offer and Consent Solicitation is to simplify the Company's capital structure and reduce the potential dilutive impact of the warrants, thereby providing the Company with more flexibility for financing its operations in the future.
globenewswire.com
- 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
globenewswire.com
- 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
prnewswire.com
- 1 week ago
Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants
ORLANDO, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (the “Company”) (NASDAQ: ABL), today announced that it intends to conduct an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) public warrants to purchase shares of common stock of the Company, par value $0.0001 per share (“common stock”), which warrants trade on The Nasdaq Capital Market under the symbol “ABLLW” (“public warrants”), and (ii) private placement warrants to purchase shares of common stock (such private placement warrants, together with the public warrants, the “warrants”).
globenewswire.com
- 1 week ago
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report - Hagens Berman
SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
prnewswire.com
- 1 week ago
8. Profile
Summary
Abacus Life, Inc. ABL
COUNTRY
US
INDUSTRY
Insurance - Life
MARKET CAP
$ 515 M
Dividend Yield
0.00%
Description
Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Contact
2101 Park Center Drive, Orlando, FL, 32835
https://abacuslife.com
IPO
Date
Sept. 14, 2020
Employees
157
Officers
Stuart Little
National Sales Director
Mr. Matthew A. Ganovsky
Co-Founder, President & Managing Partner
Mr. Kevin Scott Kirby
Co-Founder, President & Managing Partner
Mr. Jeff Smith
Vice President of Marketing
Mr. Jay J. Jackson
Chief Executive Officer, President & Chairman
Mr. Christopher David Romaine
General Counsel
Mr. Todd McNealy
Co-Founder, President & Director
Mr. William Hugh McCauley Jr.
Chief Financial Officer
Mr. Robert F. Phillips
Senior Vice President of Investor Relations & Corporate Affairs
Krissy Lubrano
Managing Director of Operations & HR